Haemoglobinuria is a condition where hemoglobin, the oxygen-carrying protein from red blood cells, appears in the urine in abnormally high amounts, often turning it dark red or brown. This happens when red blood cells break down inside blood vessels, releasing their contents into the bloodstream and eventually into the urine.
Introduction: Who Should Undergo Diagnostics
If you notice that your urine has changed to a reddish, brown, or dark color, especially during the night or early morning hours, it’s important to seek medical attention. This unusual color change is often the first visible sign that something may be wrong with your red blood cells. You should also consider getting tested if you experience other concerning symptoms alongside the discolored urine.[1]
Many people with haemoglobinuria also develop additional symptoms that affect their daily life and wellbeing. These can include shortness of breath, which happens because your body isn’t getting enough oxygen when red blood cells are being destroyed. You might also experience headaches, chest pain, or abdominal pain. Some people notice they bruise more easily than usual or develop blood clots. If you’re feeling unusually tired or weak, this could also be related to the loss of red blood cells.[3]
People who have certain existing health conditions should be particularly alert to the possibility of haemoglobinuria. If you have been diagnosed with aplastic anemia (a condition where your bone marrow doesn’t make enough blood cells) or myelodysplastic syndrome (a group of disorders caused by poorly formed blood cells), you have a higher chance of developing a condition called paroxysmal nocturnal haemoglobinuria or PNH. This is a specific form of haemoglobinuria that affects between 6 per 1 million people diagnosed each year, most commonly between the ages of 30 and 40.[2]
It’s especially important to seek diagnostics promptly because haemoglobinuria can lead to serious complications if left untreated. Without proper diagnosis and management, it may cause hemolytic anemia (a condition where you don’t have enough red blood cells because they’re being destroyed faster than your body can replace them), chronic kidney disease, or dangerous blood clots in your blood vessels. Early detection allows healthcare providers to start treatment that can prevent these complications and improve your quality of life.[2]
Diagnostic Methods
The diagnosis of haemoglobinuria typically begins with a careful review of your medical history and symptoms. Your doctor will ask you detailed questions about when you first noticed the dark urine, whether it happens at specific times of day, and what other symptoms you’ve been experiencing. They’ll also want to know about any medications you’re taking, recent infections, injuries, or burns, as these can sometimes trigger the condition.[1]
The most important initial test is a urine analysis, which is a simple laboratory examination of your urine sample. This test can detect the presence of hemoglobin in your urine even when it’s not visible to the naked eye. A key finding that helps doctors identify haemoglobinuria is when the dipstick test shows a positive result for blood, but when they look at the urine under a microscope, they don’t see actual red blood cells or red blood cell casts. This combination strongly suggests that hemoglobin, rather than whole red blood cells, is present in the urine.[1]
To understand what’s happening in your bloodstream, your doctor will order blood tests. These tests measure your hemoglobin levels, which tell doctors how many red blood cells you have and how well they’re carrying oxygen. Blood tests can also reveal whether you have anemia and show signs of red blood cells breaking apart inside your blood vessels. Your doctor may also check your lactate dehydrogenase (LDH) levels, which often increase when red blood cells are being destroyed, and your haptoglobin levels, a protein that normally cleans up free hemoglobin from your blood but becomes depleted when too many red blood cells break down.[6]
In many cases, doctors need to distinguish haemoglobinuria from other conditions that cause discolored urine. One particularly important distinction is between haemoglobinuria and myoglobinuria, a condition where muscle protein appears in the urine after muscle damage. Both can cause dark urine and give similar results on some tests, but they require very different treatments. Your healthcare provider may order additional specific tests to tell these conditions apart.[4]
When doctors suspect paroxysmal nocturnal haemoglobinuria, they use a specialized blood test called flow cytometry. This test looks at the surface of your blood cells to see if they’re missing certain protective proteins. The test specifically checks for proteins called CD55 and CD59, which normally protect red blood cells from being attacked by your immune system. When these proteins are missing or reduced, it confirms the diagnosis of PNH. This test has become the gold standard for diagnosing PNH and has largely replaced older methods.[10]
Your doctor may also need to investigate the underlying cause of your haemoglobinuria. Since many different conditions can lead to red blood cells breaking down in the blood vessels, additional tests might be necessary. These could include checking for infections like malaria or tuberculosis, looking for signs of kidney disease or kidney cancer, testing for conditions like sickle cell anemia, or investigating possible poisoning. The specific tests ordered will depend on your symptoms and medical history.[3]
If your doctor suspects that you might have bone marrow problems contributing to your condition, they may recommend a bone marrow biopsy. During this procedure, a small sample of bone marrow is removed, usually from your hip bone, and examined under a microscope. This can reveal whether your bone marrow is producing abnormal blood cells or if you have conditions like aplastic anemia or myelodysplastic syndrome that often occur alongside PNH.[2]
Distinguishing Haemoglobinuria from Similar Conditions
One of the most critical aspects of diagnosis is making sure your doctor correctly identifies haemoglobinuria rather than other causes of discolored urine. When someone presents with cranberry-colored or dark urine, it can easily be confused with hematuria, which is the presence of whole red blood cells in the urine. This confusion can lead to unnecessary procedures and delays in proper treatment. In one documented case, a woman in her 80s with intermittent dark-colored urine for several years underwent extensive urological testing before eventually being correctly diagnosed with paroxysmal nocturnal haemoglobinuria.[4]
The key to making the right diagnosis lies in specific characteristics found during testing. When looking at urine under a microscope, doctors check for the presence of red blood cells and red blood cell casts, which are tiny molds of the kidney tubules. In haemoglobinuria, the urine dipstick will test positive for blood, but the microscopic examination won’t show actual red blood cells. This tells doctors that hemoglobin protein, not whole cells, is causing the discoloration.[1]
Diagnostics for Clinical Trial Qualification
When patients with paroxysmal nocturnal haemoglobinuria consider enrolling in clinical trials to test new treatments, they must undergo specific diagnostic tests that serve as standard criteria for participation. These tests ensure that participants truly have the condition being studied and can be safely included in the research. Understanding these qualification requirements is important for anyone hoping to access experimental therapies that might not yet be widely available.
The primary test used to confirm eligibility for PNH clinical trials is flow cytometry analysis of blood cells. This test must show that a certain percentage of the patient’s red blood cells and white blood cells are missing the protective proteins GPI-anchored proteins, specifically CD55 and CD59. Different trials may require different minimum percentages of affected cells, but typically, patients need to have a substantial PNH clone, meaning a significant portion of their blood cells have the characteristic defect.[10]
Clinical trials often require evidence of active hemolysis, which means red blood cells are currently being destroyed in the bloodstream. To demonstrate this, patients must have blood tests showing elevated levels of LDH and low levels of haptoglobin. These biochemical markers provide objective evidence that the disease is active and causing problems. Trials may also require that patients have certain hemoglobin levels, often below normal ranges, to ensure the treatment being tested is appropriate for their stage of disease.[9]
Some trials specifically focus on patients who continue to have symptoms despite current treatment with existing medications. In these cases, patients must provide documentation of their current treatment regimen and demonstrate through laboratory tests that they still experience issues like anemia, need for blood transfusions, or ongoing hemolysis. The number of blood transfusions a patient has needed in recent months is often used as an objective measure of disease severity and treatment adequacy.[12]
Kidney function tests are typically required before a patient can enter a clinical trial for PNH. Because haemoglobinuria can damage the kidneys over time, researchers need to know how well a patient’s kidneys are working before they start a new experimental treatment. This baseline information helps doctors monitor for any changes in kidney function that might occur during the trial and ensures that the treatment dosing is appropriate for each patient’s kidney health.
Additional screening tests may be required depending on the specific clinical trial. Some trials require imaging studies like ultrasounds of the abdomen to check for blood clots or enlarged organs. Others may require tests to check liver function, heart health, or the presence of infections. Before starting many treatments, especially those that affect the immune system, patients typically need to show they’ve been vaccinated against certain serious infections, particularly meningococcal bacteria, which can cause life-threatening infections in people taking some PNH medications.[9]
Pregnancy testing is mandatory for women of childbearing age before entering most clinical trials for PNH. This is because pregnancy carries significant risks for women with PNH, and many experimental treatments may not be safe for use during pregnancy. Women participating in clinical trials typically must agree to use effective contraception throughout the study period and for some time afterward.


